Board Of Directors
Craig Jones
Chairman Of The Board
Craig Jones is the Managing Partner of Ticonderoga Capital. Mr. Jones co-founded Ticonderoga Capital in 1997 and has 22 years of venture capital experience focused on technology-enabled BPO services with a strong emphasis on healthcare business services. Over his extensive venture career, Mr. Jones has supervised over $500 million of venture capital investments. Mr. Jones was previously the Managing Partner of Dillon Read Venture Capital, a Partner with Advent International and an Associate with Centennial Ventures. Before commencing his career in venture capital, he was a management consultant with Bain & Company. Mr. Jones has been a director of over thirty five companies, including 14 that have completed successful initial public offerings and ten successful sales. He is a member of the Board of Directors of MarketTools, Medrium, ppoNEXT and Metal Supermarkets as well as an observer of the Board of HealthDataInsights. He was previously a member of the Board of Directors of the National Venture Capital Association. He earned a B.A. as the Outstanding Graduating Senior from California State University Sacramento and a J.D. Magna Cum Laude from Harvard Law School.
William O'Riordan, M.D.
Chief Medical Officer, Medical Division
Dr. William O’Riordan, Chairman of the Board and Chief Medical Officer, founded eStudySite in 1999 along with twelve healthcare providers with whom he’d performed research for over ten years. Dr. O’Riordan has been involved in emergency medicine for more than thirty years at St. Francis Medical Center, Paradise Valley Hospital and Sharp Chula Vista Medical Center. His academic appointments include Harbor General Hospital–UCLA Medical Center and UCSD. His nineteen years of clinical investigation has been performed at Paradise Valley Hospital and Sharp Chula Vista Medical Center. As Principal Investigator, he has directed over 70 studies including cSSSI, Stroke, Acute Myocardial Infarction, Unstable Angina, Sepsis, Septic Shock, Hospital & Community Acquired Pneumonia, Hepatitis C, Atrial Fibrillation, Congestive Heart Failure, Hyponatremia, Complicated Appendicitis, UTI/Pyleonephritis, Occluded Central Venous Access Devices, genomic studies and more. He has served as Chief of Staff at Paradise Valley Hospital and President of the American College of Emergency Physicians in California. Dr. O’Riordan has also served on numerous advisory adjudication committees including AstraZeneca, Basilea Pharmaceutica, Aventis Pharmaceuticals, Inc., Hoechst Marion Roussel among others. He is an examiner for the American Board of Emergency Medicine and a Fellow of the American College of Emergency Physicians. Dr. O’Riordan earned his medical degree from the University of Kansas Medical School and is licensed in Kansas and California.
Stephen E. Adamson
Stephen E. Adamson is the Managing Partner of Celerity Partners' Los Angeles office and has specialized in private equity since 1984. Prior to joining Celerity in 1995, Mr. Adamson took a lead role in 15 management buyouts totaling $3.6 billion in transaction value, working in New York at E.F. Hutton and Shearson Lehman Brothers, where he executed M&A transactions using the firm's capital. In 1988, Mr. Adamson moved to California and resumed his focus on middle market private equity investing, first with Integrated Resources and later with KD Equities. Mr. Adamson holds an A.B. with honors in Economics from Stanford University and an M.B.A. from the Stanford University Graduate School of Business. He is a director of SMTC Corporation and several private companies.
Mark R. Benham
Mr. Benham has eighteen years of experience in private equity and venture capital. Prior to co-founding Celerity Partners and serving as Managing Partner, from 1988-1992 he was a Senior Investment Officer of Citicorp Venture Capital, Ltd. in New York. Prior to joining Citicorp, Mr. Benham served as the U.S advisor of Yamaichi UniVen Co., Ltd, the venture capital unit of Yamaichi Securities International. Mr. Benham holds a B.A. from the University of California, Berkeley, and an M.A. and M.B.A. from The University of Chicago, both with honors. Mr. Benham is a director of Nu Visions, Verari Systems, O Premium Waters, Rincon Industries and Peer 1 Network.
David McCarthy, Jr
Joseph Panetta
Joseph Panetta has been a prominent force behind San Diego’s biotechnology sector as the first president and CEO of BIOCOM, which he transformed into the largest and most influential life science association in the U.S. Mr. Panetta has held executive management positions with The Dow Chemical Company, Mycogen Corporation, and Elf Atochem North America. He serves on a number of committees, boards, and business coalitions addressing legislation, workforce, and economic development in San Diego relative to biotechnology. He is currently on the boards of directors of the San Diego Chamber of Commerce, San Diego World Trade Center, San Diego Regional Economic Development Corporation, the San Diego Workforce Partnership; CONNECT; and Gene Therapy Systems, Inc. He serves as Advisory Council Member for several universities and was appointed by the city’s former mayor to be Commissioner of the City of San Diego Public Utilities Advisory Commission. Mr. Panetta holds a Master of Public Health from the University of Pittsburgh, Graduate School of Public Health, and a BS in Pre-Medicine/Biology from LeMoyne College.